Two more drugs from a specialty pharmacy linked to a meningitis outbreak are now being investigated, U.S. health officials said.
The New England Compounding Center of Framingham, Mass., has been under scrutiny since last month, when a rare fungal form of meningitis was linked to its steroid shots used mostly for back pain.
This week’s step by the Food and Drug Administration followed two developments. One was a report of a meningitis illness in a patient who got another type of steroid made by the company.
The agency also learned of two heart transplant patients who got fungal infections after being given a third product from the company during surgery.
The current outbreak has sickened more than 200 and caused 15 deaths.
The steroid was recalled last month, and the company later shut down operations and recalled all the medicines it makes.
The FDA this week expanded its advice to doctors to contact all patients who got any injection made by the company, including steroids and drugs used in eye surgery as well as heart operations. (AP)